Organisation paid for research Program year 2023 Source: CMS Open Payments

Behavioral Clinical Research Inc.

Neither a doctor nor a teaching hospital

Research payments

$698,968

165 payments

Through program year 2023, Behavioral Clinical Research Inc. is reported as receiving $698,968 in research payments, across 165 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$312,413	94
2021	Research	$344,564	57
2020	Research	$41,990	14

Breakdown

Who paid Research payments · program years 2020–2023

Corcept Therapeutics $386,555 71 payments
Sumitomo Pharma America, Inc. $312,413 94 payments

Studies the money was for Research payments · program years 2020–2023

Cort118335-877 $334,333 50 payments
A Double-Blind Placebo-Controlled Randomized Withdrawal Study to Evaluate SEP-363856 Physical Dependence in Adult Subjects with Schizophrenia $173,024 54 payments
A Clinical Study That Will Evalute How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antisychotic Medication $117,947 31 payments
Cort118335-876 $52,222 21 payments
A 24-Week Open-Label Study Evaluating the Effectiveness Safety and Tolerability of SEP-363856 in Subjects with Schizophrenia Switched from Typical or Atypical Antipsychotic Agents OLE. $21,442 9 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.